Literature DB >> 24814079

[The treatment of central sleep-apnea syndrome, updated information, and review of the literature].

Handan Inönü Köseoğlu1, Asiye Kanbay, Oğuz Köktürk.   

Abstract

Central sleep-apnea syndrome (CSAS) is a disease state characterized by respiratory arrest as a result of decrease or lack of respiratory drive originating from respiratory center. Although it is seen in less than 5% of the casses who consult to the sleep disorders center, incidence of CSAS increases in the presence of congestive heart and/or renal failure, and central nervous system abnormalities. Treatment of CSAS which has been analyzed under six headings in the last version of International Classification of Sleep Disorders (ICSD-2), differs among each type of CSAS. In this review, our aim is to analyze treatment alternatives for CSAS in the light of currently updated information.

Entities:  

Mesh:

Year:  2014        PMID: 24814079     DOI: 10.5578/tt.6810

Source DB:  PubMed          Journal:  Tuberk Toraks        ISSN: 0494-1373


  1 in total

1.  Cabergoline treatment in prolactinoma: Amelioration in obstructive and central sleep apneas.

Authors:  M Binar; O Karakoc; C Haymana; H Arslan
Journal:  J Postgrad Med       Date:  2019 Jan-Mar       Impact factor: 1.476

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.